Official UK procurement notice
NHS National Framework for Golimumab Injection
Authority: NHS England (Central government)
What is being bought
Published requirement descriptionNHS National Framework for Golimumab Injection commencing 1st November 2025
Offer reference number: CM/TNS/25/5724
Period of framework: 1 November 2025 to 31 October 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
CPV: Pharmaceutical products
How this framework works
From the published notice- Type
- Open framework
- Call-offs
- every call-off is a further competition among the appointed suppliers
- Bids received
- 3 bids received · 3 suppliers appointed
- Framework period
- 1 yr · up to 4 yrs from 1 Nov 2025
- Buyer regions
- UKC, UKD, UKF, UKG, UKH, UKJ, UKK
Who may buy through it
Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
Published description of the framework
Please refer to the ITO Documents for the Operation Description
The lotProcurement structure
single lot · value publishedLot #1AwardedRenewalPublished value£107,912,000
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (1)
- Price is not the only award criterion: 100%
Published award criteria (1)
- Price is not the only award criterion
- Price carries 100 of 100 points: a 10% discount moves about 10 points. This one is won on the number: sharpen the price before polishing the prose.
- “NHS National Framework for Golimumab Injection” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Above threshold (FTS publication)
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use the vehicle
- Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 4 Jun 2025, 14:23 BST
- Last source update
- 17 Oct 2025, 17:40 BST
- Award evaluation window
- Submission end – 27 Aug 2025
- Authority reference
C366698- FTS notice number
2025/S 000-039705- Latest notice
- Contract details notice (UK7)
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-052c77Find a Tender
How it was run
Official notice- Appointment period ends
- 12 Aug 2025, 13:00 BST
- Clarification deadline
- 5 Aug 2025, 12:00 BST
- Submission channel
- Official e-sourcing portal
- Electronic submission
- Allowed
- Accepted languages
- en
The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗ Additional info obtained from the abovementioned address Tenders must be submitted to the abovementioned address
Timeline
4 Jun 2025 → 1 Nov 2025 · 11 dates- Planning notice published4 Jun 2025, 14:23 BST
- Market engagement19 Jun 2025, 23:59 BST
NHS England is seeking to engage with suppliers that are planning to launch golimumab injection. Interested suppliers will be invited to a virtual 1:1 preliminary market engagement meeting. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. Please contact [email protected] or [email protected] to register your interest in tendering for this framework.
- Next notice expected27 Jun 2025, 23:59 BST
- Tender notice published14 Jul 2025, 15:39 BST
- Clarification questions by5 Aug 2025, 12:00 BST
- Admission / appointment period endsperiod end, not a bid countdown12 Aug 2025, 13:00 BST
- Award decision expected by27 Aug 2025, 23:59 BST
- Assessment summaries sent1 Sept 2025, 00:00 BST
- Standstill ends400 days ago10 Sept 2025, 23:59 BST
- Latest notice published363 days ago17 Oct 2025, 17:40 BST
- Contract starts349 days ago1 Nov 2025
Notice history
10 events · 4 releases on Find a Tender · since 4 Jun 2025- Preliminary market engagement notice published4 Jun 2025, 14:23 BSTUK2
- Tender notice published14 Jul 2025, 15:39 BSTUK4
- Published value updated to £107,912,00014 Jul 2025, 15:39 BSTwas £90,000,000
- Status changed to active14 Jul 2025, 15:39 BST
- Procurement method changed14 Jul 2025, 15:39 BST
- Deadline published: 12 Aug 2025, 13:00 BST14 Jul 2025, 15:39 BST
- Contract award notice published1 Sept 2025, 10:26 BSTUK6
- Status changed to complete1 Sept 2025, 10:26 BST
- Contract signature expected22 Sept 2025, 23:59 BSTscheduled
- Contract details notice published17 Oct 2025, 17:40 BSTUK7
Routine re-releases (4)
- 2025-06: 1 release · 4 Jun 2025
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Janssen-Cilag Ltd, Mercury Pharmaceuticals Limited, Orifarm UKSMENHS National Framework for Golimumab Injection commencing 1st November 20251 Nov 2025 – 31 Oct 2026 · up to 31 Oct 2029Extensions: option or options to extend (at the discretion of the Authority) up to maximum of 24 months. | £60,000,000 | 26 Aug 2025standstill to 10 Sept 2025 | Standstill |
Contracts
NHS National Framework for Golimumab Injection commencing 1st November 2025
- Signed
- 23 Sept 2025
- Value
- £60,000,000
- Period
- 1 Nov 2025 – 31 Oct 2026 · up to 31 Oct 2029 with extensions
- Status
- active
- Extensions
- option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 3final-stage tenders | 1 | 0 | — |
Who bid
- wonJanssen Cilag Ltd · South East England
- wonMERCURY PHARMACEUTICALS LIMITED · Greater London
- wonORIFARM UK LTD · East of England
Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.
Contracting authority & participating public bodies
Framework contractors & participating bidders
3 commercial parties on the notice- Janssen Cilag LtdFramework contractor
- MERCURY PHARMACEUTICALS LIMITEDFramework contractor
- ORIFARM UK LTDFramework contractor
Official documents & specifications (6)
Official links; attachments are not copiedTender pack and attachments
- Signed contract CONTRACT COPY - Docs - Contract Details Notice CM-TNS-25-5724
- Bidding documents and specifications
Notices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Tender notice Tender notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender